Physician profile

Daniel Lee

General Practice (Dentist) · Covington, WA

NPI 1982762639

$1,008.15

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$301.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Neoss, INC. $617.54 2021-2023 Neoss Implant System
Convergent Dental INC. $103.93 2024 Solea
Nobel Biocare USA $100.19 2019-2020
Align Technology, INC. $95.10 2021
Patterson Companies, INC. $42.82 2024
Orapharma, A Division of Bausch Health US, LLC $17.65 2019
Voco America INC. $16.68 2022
Colgate Oral Pharmaceuticals, INC. $14.24 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel Lee

$1,008.15

in general payments reported 2019-2025

Years
2019-2024
Top company
Neoss, INC.

https://glasscript.com/doctor/90317/daniel-lee

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.